Search

Gunjan Aggarwal - Criminal Judgment and Sentencing

U.S. District Court for the Northern District of California entered judgment in criminal case 4:23-cr-00428 against Gunjan Aggarwal. The defendant was sentenced to 18 months in federal prison followed by 2 years supervised release, with a $100 special assessment. A writ of garnishment was issued to collect restitution.

Phase 1 Study of HLX05-N vs ERBITUX in Metastatic Colorectal Cancer

NIH registered a Phase 1 multicentre, randomized, double-blind, parallel-controlled clinical trial (NCT07543471) comparing HLX05-N with US-sourced and EU-sourced ERBITUX in participants with metastatic colorectal cancer. Approximately 387 participants will be randomized in a 1:1:1 ratio and treated with study drug in combination with mFOLFOX6 chemotherapy. The study evaluates pharmacokinetic similarity, efficacy, safety, and immunogenicity across the three arms.